Biomaterials for stem cell culture and seeding for the generation and delivery of cardiac myocytes

Current Opinion in Organ Transplantation

Volumn 17, Issue 6, 2012, Pages 681-687

  Castells Sala, Cristina ^a   Semino, Carlos E ^a  

^a Institut Químic de Sarrià Universitat Ramon Llull   (Spain)

Author keywords

cellular therapy; growth factors; myocardial infarct; scaffolds; tissue engineering

Indexed keywords

BIOMATERIAL; HYALURONIC ACID; POLYMER; TISSUE SCAFFOLD;

ANGIOGENESIS; CELL CULTURE; CELL DIFFERENTIATION; CELL TRANSPORT; HEART FUNCTION; HEART MUSCLE CELL; HUMAN; HYDROGEL; MICROENVIRONMENT; MUSCLE REGENERATION; NONHUMAN; REVIEW; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING; TISSUE REPAIR;

BIOCOMPATIBLE MATERIALS; CELL CULTURE TECHNIQUES; HUMANS; INJECTIONS; MYOCARDIUM; MYOCYTES, CARDIAC; REGENERATION; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84870249863     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32835a34a6     Document Type: Review

References (48)

1. Stamm C, Nasseri B, Choi Y-H, Hetzer R. Cell therapy for heart disease: great expectations, as yet unmet. Heart Lung Circ 2009; 18:245-256.
2. Karam J-P, Muscari C, Montero-Menei CN. Combining adult stem cells and polymeric devices for tissue engineering in infarcted myocardium. Biomaterials 2012; 33:5683-5695.
3. Fernandes S, Kuklok S, McGonigle J, et al. Synthetic matrices to serve as niches for muscle cell transplantation. Cells Tissues Organs 2012; 195:48-59.
4. Venugopal JR, Prabhakaran MP, Mukherjee S, et al. Biomaterial strategies for alleviation of myocardial infarction, Journal of the Royal Society. Interface R Soc 2012; 9:1-19.
5. Giraud M-N, Guex AG, Tevaearai HT. Cell therapies for heart function recovery: focus on myocardial tissue engineering and nanotechnologies. Cardiol Res Pract 2012; 2012:971614.
6. Naderi H, Matin MM, Bahrami AR. Review paper: critical issues in tissue engineering: biomaterials, cell sources, angiogenesis, and drug delivery systems. J Biomat Appl 2011; 26:383-417.
7. Kleger A, Liebau S. Calcium-activated potassium channels, cardiogenesis of pluripotent stem cells, and enrichment of pacemaker-like cells. Trends Cardiovasc Med 2011; 21:74-83.
8. Chong JJH. Cell therapy for left ventricular dysfunction: an overview for cardiac clinicians. Heart Lung Circ 2012; 21:532-542. doi:10.1016/j.hlc.2012. 04.020.
9. Liu J, Zhang Z, Liu Y, et al. Generation, characterization and Potential therapeutic applications of cardiomyocytes from various stem cells. Stem Cell Dev 2012; 21:2095-2110.
10. Mullenix PS, Huddleston SJ, Stojadinovic A, et al. A new heart: somatic stem cells and myocardial regeneration. J Surg Oncol 2012; 105:475-480.
11. Clifford DM, Fisher SA, Brunskill SJ, et al. Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomes. PloS One 2012; 7:e37373.
12. Qayyum AA, Haack-Sørensen M, Mathiasen AB, et al. Adipose-derived mesenchymal stromal cells for chronic myocardial ischemia (MyStromalCell Trial): study design. Regen Med 2012; 7:421-428.
13. Weber B, Zeisberger SM, Hoerstrup SP. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth. Placenta 2011; 32 (Suppl 4):S316-S319.
14. Cortes-Morichetti M, Frati G, Schussler O, et al. Association between a cell-seeded collagen matrix and cellular cardiomyoplasty for myocardial support and regeneration. Tissue Eng 2007; 13:2681-2687. (Pubitemid 350076754)
15. Lui KO, Bu L, Li RA, Chan CW. Pluripotent stem cell-based heart regeneration: from the developmental and immunological perspectives. Birth Defects Res C Embryo Today 2012; 96:98-108.
16. Abdelli LS, Merino H, Rocher CM, Singla DK. Cell therapy in the heart. Can J Physiol Pharmacol 2012; 315: 307-315.
17. Hoover-Plow J, Gong Y. Challenges for heart disease stem cell therapy. Vasc Health Risk Manag 2012; 8:99-113.
18. Oldroyd KG, Berry C, Bartunek J. Myocardial repair and regeneration: bone marrow or cardiac stem cells? Mol Ther 2012; 20:1102-1105.
19. Gnecchi M, Danieli P, Cervio E. Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol 2012; 57:48-55.
20. Kuraitis D, Giordano C, Ruel M, et al. Exploiting extracellular matrix-stem cell interactions: a review of natural materials for therapeutic muscle regeneration. Biomaterials 2012; 33:428-443.
21. Albanna MZ, Bou-Akl TH, Walters HL, Matthew HWT. Improving the mechanical properties of chitosan-based heart valve scaffolds using chitosan fibers. J Mech Behav Biomed Mater 2012; 5:171-180.
22. Atala A. Regenerative medicine strategies. J Pediatr Surg 2012; 47:17-28.
23. Polak DJ. Regenerative medicine. Journal of the Royal Society, Interface/the Royal Society 2010; 7 (Suppl 6):S777-S781.
24. Sant S, Hancock M, Donnelly J. Biomimetic gradient hydrogels for tissue engineering. Engineering 2010; 88:899-911.
25. Demirbag B, Huri PY, Kose GT, et al. Advanced cell therapies with and without scaffolds. Biotechnol J 2011; 6:1437-1453.
26. Liu Z, Wang H, Wang Y, et al. The influence of chitosan hydrogel on stem cell engraftment, survival and homing in the ischemic myocardial microenvironment. Biomaterials 2012; 33:3093-3106.
27. Reis L, Chiu FL, Liang FY, et al. A peptide-modified chitosan-collagen hydrogel for cardiac cell culture and delivery. Acta Biomater 2012; 8:1022-1036.
28. Chimenti I, Rizzitelli G, Gaetani R, et al. Human cardiosphere-seeded gelatin and collagen scaffolds as cardiogenic engineered bioconstructs. Biomaterials 2011; 32:9271-9281.
29. Heydarkhan-Hagvall S, Gluck JM, Delman C, et al. The effect of vitronectin on the differentiation of embryonic stem cells in a 3D culture system. Biomaterials 2012; 33:2032-2040.
30. Patra C, Talukdar S, Novoyatleva T, et al. Silk protein fibroin from Antheraea mylitta for cardiac tissue engineering. Biomaterials 2012; 33:2673-2680.
31. Liau B, Christoforou N, Leong KW, Bursac N. Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function. Biomaterials 2011; 32:9180-9187.
32. Binsalamah ZM, Paul A, Khan AA, et al. Intramyocardial sustained delivery of placental growth factor using nanoparticles as a vehicle for delivery in the rat infarct model. International journal of nanomedicine 2011; 6:2667-2678.
33. Wang Y, Zhang G, Hou Y, et al. TransplantationofmicroencapsulatedSchwann cells and mesenchymal stem cells augment angiogenesis and improve heart function. Mol Cell Biochem 2012; 366:139-147. doi:10.1007/s11010-012-1291-1.
34. Cheng K, Cheng K, Malliaras K, et al. Intramyocardial injection of platelet gel promotes endogenous repair and augments cardiac function in rats with myocardial infarction. J Am Coll Cardiol 2012; 59:256-264.
35. Prabhakaran MP, Nair AS, Kai D, Ramakrishna S. Electrospun composite scaffolds containing poly(octanediol-co-citrate) for cardiac tissue engineering. Biopolymers 2012; 97:529-538.
36. Li Z, Guo X, Guan J. A Thermosensitive hydrogel capable of releasing bFGF for enhanced differentiation of mesenchymal stem cell into cardiomyocyte-like cells under ischemic conditions. Biomacromolecules 2012; 13:1956-1964. doi:10.1021/bm300574j.
37. Baumann L, Prokoph S, Gabriel C, et al. A novel, biased-like SDF-1 derivative acts synergistically with starPEG-based heparin hydrogels and improves eEPC migration in vitro. J Control Release 2012; 162:68-75.
38. Huang C-C, Wei H, Yeh Y, et al. Injectable PLGA porous beads cellularized by hAFSCs for cellular cardiomyoplasty. Biomaterials 2012; 33:4069-4077.
39. Dvir T, Timko BP, Brigham MD, et al. Nanowired three dimensional cardiac patches. Nat Nanotechnol 2012; 6:720-725.
40. Smith AW, Segar CE, Nguyen PK, et al. Long-term culture of HL-1 cardiomyocytes in modular poly(ethylene glycol) microsphere-based scaffolds crosslinked in the phase-separated state. Acta Biomaterialia 2012; 8:31-40.
41. Gallina C, Dolgetta S, Alloatti G, et al. Development of morphology and function of neonatal mouse ventricular myocytes cultured on a hyaluronan-based polymer scaffold. J Cell Biochem 2012; 113:800-807.
42. Cheng K, Blusztajn A, Shen D, et al. Functional performance of human cardiosphere-derived cells delivered in an in situ polymerizable hyaluronangelatin hydrogel. Biomaterials 2012; 33:5317-5324.
43. Kadner K, Dobner S, Franz T, et al. The beneficial effects of deferred delivery on the efficiency of hydrogel therapy post myocardial infarction. Biomaterials 2012; 33:2060-2066.
44. Gaetani R, Doevendans P, Metz CHG, et al. Cardiac tissue engineering using tissue printing technology and human cardiac progenitor cells. Biomaterials 2012; 33:1782-1790.
45. Cheng K, Shen D, Smith J, et al. Transplantation of platelet gel spiked with cardiosphere-derived cells boosts structural and functional benefits relative to gel transplantation alone in rats with myocardial infarction. Biomaterials 2012; 33:2872-2879.
46. Minato A, Ise H, Goto M, Akaike T. Cardiac differentiation of embryonic stem cells by substrate immobilization of insulin-like growth factor binding protein 4 with elastin-like polypeptides. Biomaterials 2012; 33:515-523.
47. Chachques JC, Trainini JC, Lago N, et al. Myocardial assistance by grafting a new bioartificial upgraded myocardium (MAGNUM trial): clinical feasibility study. Ann Thorac Surg 2008; 85:901-908. (Pubitemid 351260021)
48. Ling Qian, Winston Shim, Yacui Gu. Hemodynamic contribution of stem cell scaffolding in acute injured myocardium. Tissue Eng 2012; 18:1652-1663.